Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Real-time Quote. Real-time Tradegate - 10/17 10:03:19 am
118.476 EUR   -0.94%
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 BASF CEO says to look at more seed M&A after Bayer deal
10/13 Bayer sells units to be able to complete Monsanto takeover
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/11/2017 10/12/2017 10/13/2017 10/16/2017 10/17/2017 Date
117.15(c) 116.8(c) 118.15(c) 119.6(c) 118.7 Last
1 118 738 1 357 811 2 114 206 1 959 465 157 589 Volume
+0.13% -0.30% +1.16% +1.23% -0.75% Change
More quotes
Financials (€)
Sales 2017 48 368 M
EBIT 2017 9 231 M
Net income 2017 5 396 M
Debt 2017 12 235 M
Yield 2017 2,32%
Sales 2018 50 888 M
EBIT 2018 10 082 M
Net income 2018 6 074 M
Debt 2018 12 765 M
Yield 2018 2,48%
P/E ratio 2017 19,67
P/E ratio 2018 17,76
EV / Sales2017 2,30x
EV / Sales2018 2,19x
Capitalization 98 903 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
10/26 | 01:30amEarnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
10/16 BAYER : Health and Human Services Department (HHS); Food and Drug Administration..
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 BASF CEO says to look at more seed M&A after Bayer deal
10/13 Bayer sells units to be able to complete Monsanto takeover
10/13 BAYER : foundations bring tech pioneers, physicians and social entrepreneurs to ..
10/13DJBASF to Buy Large Parts of Bayer's Seed and Non-Selective Herbicide Businesse..
10/13 BAYER AKTIENGESELLSCHAFT : Release according to Article 26, Section 1 of the WpH..
10/13DJBASF : Signs Agreement To Acquire Significant Parts Of Bayer's Seed And Non-Sele..
10/13 BAYER : signs agreement to sell selected Crop Science businesses to BASF for EUR..
10/11 BAYER AKTIENGESELLSCHAFT : Release according to Article 26, Section 1 of the WpH..
More news
Sector news : Pharmaceuticals - NEC
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER 
BAYER AG - 2016
Good timing to anticipate the return of volatility
BUY
BAYER AG - 2016
A technical turn-around configuration
BUY
More Strategies
Latest Tweets
05:00aMNCs Syngenta, Bayer, Monsanto blamed for farmers deaths in Maharashtra  
10/16Bayer Motoren Werk's buy rating reiterated at Barclays PLC.  
10/16Monsanto, Bayer, DuPont, Dow Chemical and Syngenta Defend Their Coming Oligop..
10
10/16Monsanto, Bayer, DuPont, Dow Chemical and Syngenta Defend Their Coming Oli  
10/16Bayer AG given €124.00 PT by Deutsche Bank AG. buy rating.  
More tweets
Qtime:225
News from SeekingAlpha
10/16 BASF (BASFY) To Acquire Significant Parts Of Bayer's (BAYZF) Seed And Non-Sel..
10/14 BASF Buys Bayer's Crop Science Assets At A Fair Price
10/13 WALL STREET BREAKFAST : The Beat Goes On For Global Stocks As Records Continue T..
10/13 Bayer to sell seed, herbicide assets to BASF for $7B, subject to Monsanto dea..
10/12 UK's NHS to routinely offer Bayer's cancer med Stivarga
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 121 €
Spread / Average Target 1,1%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER19.19%116 409
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887